TITLE:
Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications
AUTHORS:
Tatyana Gennadyevna Borovskaya, Angelina Vladimirovna Pakhomova, Anna Vladimirovna Vychuzhanina, Marina Evgenyevna Poluektova, Tatyana Ivanovna Fomina, Lubov Aexandrovna Ermolaeva, Juliya Aexandrovna Schemerova, Oleg Konstantinovich Granstrem, Evgeniy Anatolyevich Neplochov
KEYWORDS:
Chronic Aseptic Prostatitis; Prostamax; Rats
JOURNAL NAME:
Modern Research in Inflammation,
Vol.2 No.3,
July
17,
2013
ABSTRACT: The
treatment of one of the most common urological diseases, a chronic aseptic
prostatitis, is an exigeant problem. Used methods of pharmacotherapy are
insufficiently effective and after treatment, as a rule, there comes a recrudescence.
The efficiency of new prostatotropic agent Prostamax is studied in the present
work, this drug is related to bioregulator peptides at experimental chronic
aseptic inflammation of prostate gland. It is established that Prostamax
reduces intensity of signs of a chronic inflammation (swelling, hyperemia of
vessels, lymphoid infiltration), prevents development of sclerotic and atrophic
processes. It is shown that the agent intensifies sexual activity of animals.
Efficiency of the preparation Prostamax surpasses that among widespread
prostatotropic agents derived from the extract of Serenoa repens and prostate
of animals.